On the 31st of December, Sands Capital Management purchased 3.1 million iRhythm Technologies Inc. (IRTC) shares for $729 million at an average price of $237.21 per share.
Shares of iRhythm Technologies Inc. are down -2.13% since the transaction.
Sands Capital Management’s holding in iRhythm Technologies Inc. established a new holding of about 3.1 million shares with the purchase.
Sands Capital Management first bought iRhythm Technologies Inc. stock in the third quarter of 2020.
Sands Capital Management also owns DexCom Inc (DXCM), Align Technology Inc (NASDAQ:), Zoetis (NYSE:) and ABIOMED Inc (ABMD).
IRhythm Technologies Inc. is its number three position by number of shares and market value among health care supplies stocks.
Other investors who also established new holdings in iRhythm Technologies Inc. include Millennium Management and Carillon Tower Advisers.
In contrast, Citigroup (NYSE:), the T. Rowe Price Equity Income Fund, and TimesSquare Capital Management reduced IRTC shares.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.